119 related articles for article (PubMed ID: 12554076)
1. Effects of cholesterol on dye leakage induced by multidrug-resistance modulators from anionic liposomes.
Castaing M; Loiseau A; Djoudi L
Eur J Pharm Sci; 2003 Jan; 18(1):81-8. PubMed ID: 12554076
[TBL] [Abstract][Full Text] [Related]
2. Thermal dependence of multidrug-resistant-modulator efficiency: a study in anionic liposomes.
Castaing M; Loiseau A; Dani M
J Pharm Pharmacol; 2000 Oct; 52(10):1171-8. PubMed ID: 11092560
[TBL] [Abstract][Full Text] [Related]
3. Designing multidrug-resistance modulators circumventing the reverse pH gradient in tumours.
Castaing M; Loiseau A; Dani M
J Pharm Pharmacol; 2001 Jul; 53(7):1021-8. PubMed ID: 11480537
[TBL] [Abstract][Full Text] [Related]
4. Membrane permeation by multidrug-resistance-modulators and non-modulators: effects of hydrophobicity and electric charge.
Castaing M; Brouant P; Loiseau A; Santelli-Rouvier C; Santelli M; Alibert-Franco S; Mahamoud A; Barbe J
J Pharm Pharmacol; 2000 Mar; 52(3):289-96. PubMed ID: 10757416
[TBL] [Abstract][Full Text] [Related]
5. Interactions between verapamil and neutral and acidic liposomes: effects of the ionic strength.
Castaing M; Loiseau A; Mulliert G
Biochim Biophys Acta; 2003 Apr; 1611(1-2):107-14. PubMed ID: 12659951
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance modulator interactions with neutral and anionic liposomes: membrane binding affinity and membrane perturbing activity.
Castaing M; Loiseau A; Mulliert G
J Pharm Pharmacol; 2005 May; 57(5):547-54. PubMed ID: 15901343
[TBL] [Abstract][Full Text] [Related]
7. Synergy between verapamil and other multidrug -resistance modulators in model membranes.
Castaing M; Loiseau A; Cornish-Bowden A
J Biosci; 2007 Jun; 32(4):737-46. PubMed ID: 17762146
[TBL] [Abstract][Full Text] [Related]
8. Role of GPI-anchored enzyme in liposome detergent-resistance.
Morandat S; Bortolato M; Roux B
J Membr Biol; 2003 Feb; 191(3):215-21. PubMed ID: 12571756
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability.
Drori S; Eytan GD; Assaraf YG
Eur J Biochem; 1995 Mar; 228(3):1020-9. PubMed ID: 7737146
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of reactive and stable glucose oxidase-containing liposomes modulated with detergent.
Yoshimoto M; Wang S; Fukunaga K; Walde P; Kuboi R; Nakao K
Biotechnol Bioeng; 2003 Mar; 81(6):695-704. PubMed ID: 12529883
[TBL] [Abstract][Full Text] [Related]
11. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and chemical characterization of 2-methoxy-N(10)-substituted acridones needed to reverse vinblastine resistance in multidrug resistant (MDR) cancer cells.
Krishnegowda G; Thimmaiah P; Hegde R; Dass C; Houghton PJ; Thimmaiah KN
Bioorg Med Chem; 2002 Jul; 10(7):2367-80. PubMed ID: 11983534
[TBL] [Abstract][Full Text] [Related]
13. The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
Krishna R; Mayer LD
Anticancer Res; 1999; 19(4B):2885-91. PubMed ID: 10652569
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the detergent-induced membrane permeability and solubilization of saturated phosphatidylcholine/cholesterol liposomes: effects of poly(ethylene glycol)-conjugated lipid.
Shibata H; Saito H; Yomota C; Kawanishi T; Okuda H
Chem Pharm Bull (Tokyo); 2012; 60(9):1105-11. PubMed ID: 22976317
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity.
Tang J; Zhang L; Gao H; Liu Y; Zhang Q; Ran R; Zhang Z; He Q
Drug Deliv; 2016 May; 23(4):1130-43. PubMed ID: 25491241
[TBL] [Abstract][Full Text] [Related]
16. Corticoids modulate liposome membrane fluidity and permeability depending on membrane composition and experimental protocol design.
Kaddah S; Khreich N; Kaddah F; Khrouz L; Charcosset C; Greige-Gerges H
Biochimie; 2018 Oct; 153():33-45. PubMed ID: 29935242
[TBL] [Abstract][Full Text] [Related]
17. Cargoing P-gp inhibitors via nanoparticle sensitizes tumor cells against doxorubicin.
Singh MS; Lamprecht A
Int J Pharm; 2015 Jan; 478(2):745-52. PubMed ID: 25437111
[TBL] [Abstract][Full Text] [Related]
18. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
[TBL] [Abstract][Full Text] [Related]
19. Photophysical studies of some dyes in aqueous solution of triton X-100.
Bhowmik BB; Ganguly P
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Dec; 62(4-5):808-13. PubMed ID: 15893955
[TBL] [Abstract][Full Text] [Related]
20. Adsorption of a cationic dye molecule on polystyrene microspheres in colloids: effect of surface charge and composition probed by second harmonic generation.
Eckenrode HM; Jen SH; Han J; Yeh AG; Dai HL
J Phys Chem B; 2005 Mar; 109(10):4646-53. PubMed ID: 16851544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
